Phadia
UPPSALA, Sweden, August 23, 2011 -
HighCapacity Instruments,Combining AllergyandAutoimmunity Testing BasedonProvenPhadiaTechnologyforReliability
Today Phadia, the global leader in allergy and autoimmune related diseases diagnostics, announced the launch of Phadia's new allergy and autoimmunity testing instruments; Phadia 2500 and Phadia 5000.
UPPSALA, Sweden and COPENHAGEN, Denmark, August 22, 2011 -
Phadia AB and Biomonitor A/S announced today a collaboration in the field of immunogenicity testing and monitoring of patients treated with biopharmaceutical drugs.
UPPSALA, Sweden, June 20, 2011 -
510(K) Clearance Covers 13 Molecular
Allergen Components
Newly-available tests provide deepest clinical insight into
peanut allergy, as well as allergies to cat dander, dust mite,
Bermuda grass, ragweed, and fungi enabling a significant
improvement in the clinical management of patients with suspected
allergies.
UPPSALA, Sweden, June 14, 2011 -
Precise assessment of patients with allergy to bee and wasp
venoms helps allergists to identify the optimal venom immunotherapy
(VIT) in each case.
UPPSALA, Sweden, June 14, 2011 -
Bees, wasps and bumble bees pose a
real health threat to individuals with venom allergy.
More News
- ImmunoCAP(R) Used in Largest Cross-sectional Allergy Study Ever
- New NICE Guidelines - All Children and Young People With Suspected Food Allergy Should be Offered an Allergy Test
- New NICE Guideline Places Child and Young Person Food Allergy Management in the Hands of GP's and Other Healthcare Professionals in Primary Care and the Community
- Phadia Allergy and Autoimmunity Products Commercially Approved in India
- Phadia Acquires Nanjing Wei Kang Le Trade Co., (WKL) in China
- New NIH Guidelines Advocate ImmunoCAP Blood Test to Improve Diagnosis of Food Allergy
- /C O R R E C T I O N — Phadia/
